Ellington Financial amends and expands $500 million at-the-market stock offering
Ellington Financial amended its existing equity distribution agreements and added Citadel Securities and Moelis & Company as sales agents for its at-the-market common stock offering. The offering now has up to $500 million of common stock available for sale through the agents, issued under an automatic shelf registration statement. Shareholders may face dilution if these shares are sold, though the company has no obligation to sell any shares.
Key points
- On December 23, 2025, the company amended its existing sales agreements dated September 30, 2024 and entered new agreements with Citadel Securities and Moelis & Company.
- Shares with a maximum aggregate offering price of up to $500 million remain available for sale through the agents.
- Each agent is entitled to compensation of up to 2.0% of gross proceeds from shares it sells.
- The shares will be issued under Form S-3 (File No. 333-292424) with a prospectus supplement dated December 23, 2025.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 29, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.